Burton DR - Search Results

1

Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development.

Andrabi R, Su CY, Liang CH, Shivatare SS, Briney B, Voss JE, Nawazi SK, Wu CY, Wong CH, Burton DR. Andrabi R, et al. Among authors: burton dr. Immunity. 2017 Sep 19;47(3):524-537.e3. doi: 10.1016/j.immuni.2017.08.006. Epub 2017 Sep 12. Immunity. 2017. PMID: 28916265 Free PMC article.

2

Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure.

Ditzel HJ, Binley JM, Moore JP, Sodroski J, Sullivan N, Sawyer LS, Hendry RM, Yang WP, Barbas CF 3rd, Burton DR. Ditzel HJ, et al. Among authors: burton dr. J Immunol. 1995 Jan 15;154(2):893-906. J Immunol. 1995. PMID: 7529290

3

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody.

Burton DR, Pyati J, Koduri R, Sharp SJ, Thornton GB, Parren PW, Sawyer LS, Hendry RM, Dunlop N, Nara PL, et al. Burton DR, et al. Science. 1994 Nov 11;266(5187):1024-7. doi: 10.1126/science.7973652. Science. 1994. PMID: 7973652

4

Human antibodies to HIV-1 by recombinant DNA methods.

Burton DR, Barbas CF 3rd. Burton DR, et al. Chem Immunol. 1993;56:112-26. Chem Immunol. 1993. PMID: 8452652 Review. No abstract available.

5

A vaccine for HIV type 1: the antibody perspective.

Burton DR. Burton DR. Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10018-23. doi: 10.1073/pnas.94.19.10018. Proc Natl Acad Sci U S A. 1997. PMID: 9294155 Free PMC article. Review.

6

The antibody response in HIV-1 infection.

Burton DR, Montefiori DC. Burton DR, et al. AIDS. 1997;11 Suppl A:S87-98. AIDS. 1997. PMID: 9451972 Review. No abstract available.

7

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo.

Poignard P, Sabbe R, Picchio GR, Wang M, Gulizia RJ, Katinger H, Parren PW, Mosier DE, Burton DR. Poignard P, et al. Among authors: burton dr. Immunity. 1999 Apr;10(4):431-8. doi: 10.1016/s1074-7613(00)80043-6. Immunity. 1999. PMID: 10229186 Free article.

8

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

Zwick MB, Labrijn AF, Wang M, Spenlehauer C, Saphire EO, Binley JM, Moore JP, Stiegler G, Katinger H, Burton DR, Parren PW. Zwick MB, et al. Among authors: burton dr. J Virol. 2001 Nov;75(22):10892-905. doi: 10.1128/JVI.75.22.10892-10905.2001. J Virol. 2001. PMID: 11602729 Free PMC article.

9

Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies.

Zwick MB, Wang M, Poignard P, Stiegler G, Katinger H, Burton DR, Parren PW. Zwick MB, et al. Among authors: burton dr. J Virol. 2001 Dec;75(24):12198-208. doi: 10.1128/JVI.75.24.12198-12208.2001. J Virol. 2001. PMID: 11711611 Free PMC article.

10

Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.

Moulard M, Phogat SK, Shu Y, Labrijn AF, Xiao X, Binley JM, Zhang MY, Sidorov IA, Broder CC, Robinson J, Parren PW, Burton DR, Dimitrov DS. Moulard M, et al. Among authors: burton dr. Proc Natl Acad Sci U S A. 2002 May 14;99(10):6913-8. doi: 10.1073/pnas.102562599. Epub 2002 May 7. Proc Natl Acad Sci U S A. 2002. PMID: 11997472 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

668 results

Search Page

Filters